Stress, Visceral Obesity, and Metabolic Complications
- 17 November 2006
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1083 (1) , 77-110
- https://doi.org/10.1196/annals.1367.008
Abstract
Abstract: Stress is a state of threatened homeostasis or disharmony caused by intrinsic or extrinsic adverse forces and is counteracted by an intricate repertoire of physiologic and behavioral responses that aim to reestablish the challenged body equilibrium. The adaptive stress response depends upon an elaborate neuroendocrine, cellular, and molecular infrastructure, the stress system. Crucial functions of the stress system response are mediated by the hypothalamic‐pituitary‐adrenal (HPA) axis and the central and peripheral components of the autonomic nervous system (ANS). The integrity of the HPA axis and the ANS and their precise interactions with other CNS components are essential for a successful response to the various stressors. Chronic stress represents a prolonged threat to homeostasis by persistent or frequently repeated stressors and may lead to manifestations that characterize a wide range of diseases and syndromes. Such states progressively lead to a deleterious overload with complications caused by both the persistent stressor and the detrimental prolongation of the adaptive response. The metabolic syndrome can be described as a state of deranged metabolic homeostasis characterized by the combination of central obesity, insulin resistance, dyslipidemia, and hypertension. The incidence of both obesity and the metabolic syndrome in modern Western societies has taken epidemic proportions over the past decades and often correlates with indices of stress in the affected populations. Stress, primarily through hyperactivation of the HPA axis, appears to contribute to the accumulation of fat tissue, and vice versa, obesity itself seems to constitute a chronic stressful state and may cause HPA axis dysfunction. In addition, the description of obesity as a systemic low grade inflammatory condition that contributes to the derangement of the metabolic equilibrium implies that the proinflammatory cytokines which are secreted by the adipocytes hold a potentially important pathogenetic role. In this article we describe the physiology of the stress system response, with emphasis on metabolism, and review the recent data that implicate several neuroendocrine and inflammatory mechanisms mobilized during chronic stress in the development of the metabolic complications that characterize central obesity and the metabolic syndrome.Keywords
This publication has 128 references indexed in Scilit:
- The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practiceJournal of the American College of Cardiology, 2005
- The metabolic syndrome — a neuroendocrine disorder?British Journal of Nutrition, 2000
- The Growth Hormone Secretagogue Hexarelin Stimulates the Hypothalamo-Pituitary-Adrenal Axis via Arginine VasopressinJournal of Clinical Endocrinology & Metabolism, 1999
- Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brainJournal of Comparative Neurology, 1999
- The Human Corticotropin-Releasing Factor Receptor (CRHR) Gene Maps to Chromosome 17q12-q22Genomics, 1995
- The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated InflammationNew England Journal of Medicine, 1995
- Substance P Inhibits the Release of Anterior Pituitary Adrenocorticotrophin via a Central Mechanism Involving Corticotrophin‐Releasing Factor‐Containing Neurons in the Hypothalamic Paraventricular NucleusJournal of Neuroendocrinology, 1993
- Participation of α1-Adrenergic Receptors in the Secretion of Hypothalamic Corticotropin- Releasing Hormone during StressNeuroendocrinology, 1992
- Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.Journal of Clinical Investigation, 1988
- Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.Journal of Clinical Investigation, 1988